J&J Challenged Over Schizophrenia Drug Patent
Barr Laboratories Inc. has challenged Johnson & Johnson's patent for a schizophrenia drug, triggering a lawsuit from the health care giant over the widely prescribed antipsychotic....To view the full article, register now.
Already a subscriber? Click here to view full article